NABsys is developing its proprietary Hybridization-Assisted Nanopore Sequencing (HANS) platform. This platform combines bleeding edge technology in physics, biochemistry, and computer science to sequence DNA in a way that is projected to be orders of magnitude cheaper and faster than any technology available today.
The company manufactures the Bio-Assembler, a device for culturing cells in three-dimensions by magnetic levitation. The Bio-Assembler combines nanoparticle based Nanoshuttle-PL with designed magnetic fields needed to levitate cells and provide the 3D cell growth environment.
NanoDrop Technologies manufactures and sells unique analytical instruments based upon patented sample retention technology. These instruments are used globally in biotechnology, pharmaceutical and life science research.
NanoEngineering (NEC) is focused on viruses and size-based detection of sub-cellular biomolecules. The company is building the next-generation of Virus Screening technology into an easy-to-use, fast and affordable system to rapidly screen, identify and quantify Viruses from complex mixtures.
Nanofiber Solutions designs and manufactures novel 3D nanofiber scaffolds. The company's 3D cell culture products NanoAligned and NanoECM were developed for life science research. Nanofiber Solutions novel platform technology provides researchers with more biologically realistic 3-dimensional in vivo cell culture environment.
NanoLight Technologies is a division of Prolume Ltd., a biotechnology company developing broad applications of natural, light-emitting marine proteins, or marine bioluminescence. The NanoLight division is focused on becoming the leader in high-value reagent & reporter systems for new product development in the pharmaceutical, agrichemical, and research products industries.
NanoMedical Systems (NMS) is a startup company, which will commercialize the patented research of Dr. Mauro Ferrari at the University of Texas Health Science Center in Houston, a sponsored research site and a source of licensed IP for NMS. The company's Personalized Molecular Drug-delivery System (PMDS) is a small drug delivery device that is implanted subcutaneously (just under the skin) for slow and consistent release of a therapeutic agent over many weeks or months. A nanochannel delivery system (nDS) embodied on a silicon chip regulates the flow of therapeutic molecules.
nanoRETE, Inc. provides real-time detection of pathogens using customized nanoparticle biosensors. The company has developed a platform that has the ability to test for numerous pathogens (anthrax, E. Coli, salmonella, tuberculosis, etc.) using a simple-to-use handheld device which generates screening results in about one hour.